foxo4-dri senolytic peptide 2024 study The disordered p53 transactivation domain is the target of FOXO4 and the compound FOXO4-DRI Peptide - 10 mg
FOXO4 DRI Peptide 10 mg FOXO4 DRI Peptide Nationwide Peptides By National Science Labs, LLC Molecular modelling of the FOXO4 TP53 interaction to design senolytic peptides for the elimination of senescent cancer cells ScienceDirect FOXO4 DRI Wikipedia
Pay in 4 interest-free payments of $6.24 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 6 - Aug 11


